What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

INTRODUCTION: Minimum clinically important difference (MCID) is a measure that defines the minimum amount of change in an objective score of a clinical test that must be reached for that change to be clinically noticeable. We aimed to find the MCID for patients with predominantly negative symptoms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Czobor, Pál, Sebe, Barbara, Acsai, Károly, Barabássy, Ágota, Laszlovszky, István, Németh, György, Furukawa, Toshi A., Leucht, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083222/
https://www.ncbi.nlm.nih.gov/pubmed/35546918
http://dx.doi.org/10.3389/fpsyt.2022.816339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083222/
https://www.ncbi.nlm.nih.gov/pubmed/35546918
http://dx.doi.org/10.3389/fpsyt.2022.816339

Ejemplares similares